DermTech, Inc.
DMTKDelisted Jul 19, 2024- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001651944
DermTech, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 12, 2024; 69 institutions reported holding it in 13F filings for Q1 2024, worth $3.03M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by DermTech, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for DermTech, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sun Kevin M | Chief Financial Officer | 269,216 | Jun 12, 2024 | 0 |
| Akhavan Ramin | General Counsel | 128,425 | Jun 7, 2024 | 0 |
| Ibarra Claudia | Chief Operating Officer | 193,547 | Dec 11, 2023 | 0 |
| Aguillard Mark Bryan | Chief Commercial Officer | 90,000 | Sep 22, 2023 | 0 |
| Wood Todd Michael | Chief Commercial Officer | 284,757 | Jun 14, 2023 | 0 |
| Rosenman Herm | Director | 134,576 | Jun 5, 2023 | 0 |
| Malloy Kirk | Director | 86,459 | Jun 5, 2023 | 0 |
| Capone Mark Christopher | Director | 82,054 | Jun 5, 2023 | 0 |
| Collins Cynthia | Director | 104,835 | Jun 5, 2023 | 0 |
| Posard Matthew L. | Director | 158,215 | Jun 5, 2023 | 0 |
| Keraudy Nathalie Gerschtein | Director | 69,689 | Jun 5, 2023 | 0 |
| Christensen Bret | Chief Executive Officer | – | May 10, 2023 | 0 |
| Dobak John | Chief Executive Officer | 698,693 | Apr 6, 2023 | 0 |
| RTW Investments, LP | 10% Owner | 3,018,666Indirect | Nov 8, 2022 | 0 |
| Wong Roderick | 10% Owner | 3,018,666Indirect | Nov 8, 2022 | 0 |
| Tellado Monica | Director | 35,099 | May 31, 2022 | 0 |
| Pancoast Scott R | Director | 50,696 | Jul 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 (view filing) | Dec 8 | 2 days | Dobak JohnChief Executive Officer | SSale | −1.12K | $18.46 | −$20.7K | −0.2%452.5K after | |
| Sep 15, 2021 (view filing) | Sep 13-14 | 2 days | Wood Todd MichaelChief Commercial Officer | SSale | −1.77K | $35.78 | −$63.5K | −1.2%145.5K after | 3 lots |
| Sep 15, 2021 (view filing) | Sep 13 | 2 days | Sun Kevin MChief Financial Officer | SSale | −622 | $36.19 | −$22.5K | −0.4%149.9K after | |
| Sep 15, 2021 (view filing) | Sep 13 | 2 days | Ibarra ClaudiaChief Operating Officer | SSale | −457 | $36.19 | −$16.5K | −0.4%114.1K after | |
| Sep 15, 2021 (view filing) | Sep 13 | 2 days | Dobak JohnChief Executive Officer | SSale | −1.90K | $36.19 | −$68.7K | −0.4%453.6K after | |
| Sep 10, 2021 (view filing) | Sep 8 | 2 days | Wood Todd MichaelChief Commercial Officer | SSale | −442 | $36.18 | −$16.0K | −0.3%147.3K after | |
| Sep 10, 2021 (view filing) | Sep 8 | 2 days | Sun Kevin MChief Financial Officer | SSale | −4.28K | $36.19 | −$154.7K | −2.8%150.6K after | |
| Sep 10, 2021 (view filing) | Sep 8 | 2 days | Ibarra ClaudiaChief Operating Officer | SSale | −3.02K | $36.18 | −$109.3K | −2.6%114.6K after | |
| Sep 10, 2021 (view filing) | Sep 8 | 2 days | Dobak JohnChief Executive Officer | SSale | −1.16K | $36.19 | −$42.1K | −0.3%455.5K after | |
| Jul 2, 2021 (view filing) | Jun 30 | 2 days | Pancoast Scott RDirector | SSale | −5.00K | $42.41 | −$212.1K | −9.4%48.3K after | 2 lots |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Dobak JohnChief Executive Officer | SSale | −12.5K | $41.07 | −$513.4K | −2.7%456.3K after | 2 lots |